Literature DB >> 2550541

Platelet cytosolic proton and free calcium concentrations in essential hypertension.

C Astarie1, J Levenson, A Simon, P Meyer, M A Devynck.   

Abstract

Alterations in the metabolism of intracellular messengers, such as calcium and cyclic adenosine 5'-phosphate (cAMP), have been reported in essential hypertension. Since intracellular pH (pHi) participates in the control of fundamental cell functions, we looked for changes in platelet cytosolic H+ concentration [( H+]i) in hypertension and investigated whether or not its impaired metabolism is linked to the calcium handling abnormalities. The fluorescent pH indicator BCECF has been used to evaluate intracellular H+ concentration in platelets, unstimulated ex vivo, from normotensive (n = 20) and hypertensive patients (n = 20). Cytosolic [H+] was 20% lower in hypertensive than in normotensive subjects (49.5 +/- 3.4 and 61.8 +/- 2.2 nmol/l cells, respectively, P less than 0.005; mean pHi values were 7.21 and 7.33, respectively). Platelet cytosolic H+ and free Ca2+ concentrations ([Ca2+]i) were determined in parallel in 15 normotensive and 15 hypertensive patients. [Ca2+]i was found to be 19% higher (P less than 0.01), and [H+]i 22% lower (P less than 0.02), in the hypertensive patients compared with the normotensive subjects. Platelet pHi and [Ca2+]i were increased simultaneously in some hypertensive patients. These results are compatible with the hypothesis of an in vivo activation of platelets in hypertension. If a similar alkalinization exists in smooth muscle cells, it may participate in cell proliferation and in an enhanced sensitivity to agonists, two parameters thought to be involved in blood pressure elevation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2550541     DOI: 10.1097/00004872-198906000-00008

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  4 in total

1.  Modulation of platelet Ca2+ homeostasis by hypertensive plasma factor(s) derived from patients with early-stage renal disease.

Authors:  H Schiffl
Journal:  Klin Wochenschr       Date:  1991-12-11

2.  Platelet calcium pump activity in essential hypertensives and their first-degree relatives.

Authors:  S Gulati; M Khullar; B K Sharma; N K Ganguly
Journal:  Mol Cell Biochem       Date:  1996-03-09       Impact factor: 3.396

3.  In vitro inhibition by endothelins of thrombin-induced aggregation and Ca2+ mobilization in human platelets.

Authors:  C Astarie-Dequeker; L Iouzalen; M David-Dufilho; M A Devynck
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

4.  Different effects of endothelin-3 on the Ca2+ discharge induced by agonists and Ca(2+)-ATPase inhibitors in human platelets.

Authors:  C Astarie-Dequeker; I Korichneva; M A Devynck
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.